EBS
Emergent BioSolutions Inc.
NYSE · USHealthcareDrug Manufacturers - Specialty & Generic
$7.69+0.79%
Price as of Jul 20, 2026
EBS analysis
Emergent BioSolutions Inc. stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for EBS is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research